QPharma Inc. reported this breach to the Maryland Attorney General. Affected individuals who received a notification letter may be entitled to financial compensation through a class action lawsuit — at no cost to you.
According to the Maryland Attorney General filing, the following types of personal information were compromised in the QPharma Inc. data breach:
Each type of exposed data strengthens your legal claim. Courts have consistently recognized that the unauthorized disclosure of this information constitutes actionable harm.
QPharma Inc. operates as a specialized healthcare compliance, commercial support, and data management provider, serving the pharmaceutical, life sciences, and medical device industries. Because of its core operational focus, the company acts as a vital bridge between drug manufacturers, healthcare providers, and patients. In this capacity, QPharma collects, processes, and stores an extensive volume of highly sensitive information, including proprietary pharmaceutical data, clinical trial metrics, healthcare provider credentials, and confidential patient records. The nature of its services requires the centralization of vast data repositories containing personally identifiable information (PII) and protected health information (PHI), making the organization a high-value target for malicious actors seeking to exploit valuable health sector data assets.
In 2025, QPharma Inc. reported a significant data security incident to the Maryland Attorney General, triggering widespread concern among individuals whose data was entrusted to the company. While the exact vectors of such cyberattacks often involve sophisticated ransomware deployment, unauthorized network infiltration, or third-party vendor compromises, incidents affecting specialized healthcare services companies typically exploit vulnerabilities in digital supply chains or legacy infrastructure. In the life sciences and healthcare data sector, threat actors frequently target network perimeters to gain unauthorized access to centralized databases where sensitive operational and personal files are stored, evading initial detection until exfiltration has already occurred.
The exposure of sensitive records in a healthcare data breach creates severe, multi-faceted risks for affected individuals. Compromised data categories frequently include full names, dates of birth, Social Security numbers, medical record identifiers, insurance policy details, and specialized pharmaceutical or clinical program information. Unlike standard retail breaches, the theft of health-related and administrative identifiers can facilitate targeted medical fraud, unauthorized prescriptions, and complex identity theft schemes. When malicious actors obtain comprehensive personal profiles alongside healthcare context, victims face prolonged risks of fraudulent medical billing, compromised insurance benefits, and the permanent exposure of intimate personal health details that cannot simply be reset like a password.
As an entity handling sensitive personal and health-related information, QPharma Inc. is bound by stringent federal and state legal frameworks, including the Health Insurance Portability and Accountability Act (HIPAA), the Maryland Personal Information Protection Act, and applicable state consumer protection laws. These regulatory standards mandate robust administrative, physical, and technical safeguards to ensure the confidentiality, integrity, and availability of electronic protected health information. A data breach of this magnitude serves as prima facie evidence of potential systemic failures in maintaining adequate cybersecurity defenses, patching known vulnerabilities, or properly vetting third-party access points, thereby breaching the duty of care owed to consumers and clients.
Receiving an official data breach notification letter from QPharma Inc. is a formal acknowledgment by the company that your confidential information was compromised as a result of their inadequate security measures. Legally, this notice establishes the concrete injury and standing necessary to participate in a class action lawsuit aimed at holding the company accountable for its security lapses. Affected individuals do not need to prove that financial fraud has already occurred to seek legal redress; the increased risk of future identity theft and the loss of privacy are recognized harms. Our firm investigates these matters on a contingency fee basis, meaning there are never any out-of-pocket costs or upfront fees, and we only collect compensation if we successfully recover damages on your behalf.
You do not need to prove you were financially harmed to qualify. Courts have recognized that the exposure of personal data itself constitutes actionable harm. You may qualify if any of the following apply:
You received a data breach notification letter from QPharma Inc.
You were a customer, patient, employee, or client of QPharma Inc.
Your personal information was stored in QPharma Inc.'s systems
Your Social Security number or driver's license number was exposed
Your medical records, diagnoses, or health insurance information was compromised
You reside in the United States (all 50 states eligible)
That letter is legally required and confirms your data was exposed. It also gives you standing to file a claim.
What your notification letter means & what to do next →Take these steps immediately to protect yourself and preserve your right to compensation.
Your QPharma Inc. data breach notification letter is legal evidence. Store it in a safe place — physical and digital copies. It establishes that you were affected by this breach and strengthens your claim for compensation.
QPharma Inc. is typically required to offer free credit monitoring to affected individuals. Check your notification letter for enrollment instructions and use all offered services — they help detect fraud early and document harm.
Contact Equifax, Experian, and TransUnion to place a free credit freeze. This prevents new accounts from being opened in your name and protects you from identity theft. You can lift the freeze at any time.
You have a limited window to file a claim. Contact our attorneys today for a free, no-obligation case review. We handle all QPharma Inc. data breach cases on a contingency basis — you pay nothing unless we win.
Security Incident
Prior to AG notification
Unauthorized access to QPharma Inc.'s systems containing personal information.
Reported to Attorney General
February 27, 2025
QPharma Inc. filed an official data breach notice with the Maryland AG.
Consumer Notification Letters Sent
Within weeks of AG filing
State law requires companies to mail notification letters to all affected individuals.
Legal Window — Act Now
Statute of limitations applies
State law sets a deadline to file claims. Waiting can forfeit your right to compensation.
Data breach victims may be entitled to several forms of compensation. The specific amounts depend on your state, the type of data exposed, and the company's conduct.
States like California allow $100–$750 per incident regardless of actual harm. Other states provide separate statutory remedies for data breach victims.
Reimbursement for any fraud charges, unauthorized transactions, or expenses you incurred as a direct result of the breach.
Compensation for hours spent monitoring accounts, disputing fraud, freezing credit, and dealing with the aftermath of the breach.
Reimbursement for the cost of credit monitoring services, identity theft protection, and related identity restoration expenses.
SSN and driver's license exposure creates long-term identity theft risk. Courts recognize the ongoing value of this harm and may award damages accordingly.
The unauthorized exposure of health and medical information may trigger HIPAA-related claims and additional state health privacy protections.
Maryland's Personal Information Protection Act (PIPA) requires companies to implement reasonable security measures. Violations can support statutory damages claims even without proof of financial harm.
These companies also reported data breaches to the Maryland Attorney General. If you received a letter from any of these organizations, you may also be entitled to compensation.
Lyon Management Group, Inc.
Maryland · Jan 2025
Cabrillo College
Maryland · Feb 2025
Christopher L. Mewborn, Attorney, P.A. d/b/a Mewborn & DeSelms, Attorneys at Law
Maryland · Feb 2025
Ott Cone & Redpath, P.A.
Maryland · Jan 2025
ChurchShield
Maryland · Jan 2025
LBX Company LLC
Maryland · Jan 2025
Contact us for a FREE consultation. No fee unless we win your case.
(786) 306-7278Free Claim ReviewLaw Office of David S. Harris